Geneos Wealth Management Inc. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$26,000
+4.0%
2000.0%0.00%0.0%
Q3 2021$25,000
+4.2%
2000.0%0.00%0.0%
Q2 2021$24,000
+9.1%
2000.0%0.00%0.0%
Q1 2021$22,000
-8.3%
2000.0%0.00%0.0%
Q4 2020$24,000
+60.0%
2000.0%0.00%0.0%
Q3 2020$15,000
-28.6%
2000.0%0.00%0.0%
Q2 2020$21,000
+200.0%
200
+100.0%
0.00%
Q1 2020$7,0001000.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders